How individually rare genetic variants converge on shared disease mechanisms.
A non-profit institute, built to advance the world's understanding of biology.
REELD exists for one reason: to further human understanding of biology — genetics, cellular systems, and the mechanisms of disease — for the good of everyone it touches.
Our premise
Why we exist
REELD is a non-profit educational research institute, founded in 2016. We are not built to generate proprietary advantage or shareholder return. We are built to generate understanding — of rare genetic variation, single-cell biology, phenotype ontology, and the disease mechanisms that connect them — and to put that understanding into the world where it can be used, tested, and built upon.
At the center of our mission is a simple belief: biology is too important, and too difficult, for any one lab to understand alone. Progress comes from shared evidence, shared scrutiny, and shared standards.
The cell types, cell states, and developmental windows where disease mechanisms become visible.
How clinical observations can be represented, compared, and reasoned about rigorously.
Turning convergent evidence into falsifiable hypotheses that can guide real experiments.
Research alongside the academic world
REELD's research draws on our own findings, alongside engagement with the work of investigators and laboratories at leading research universities, including Stanford, MIT, and The University of Texas. Naming an institution reflects engagement with its research or scholars — not a formal or exclusive partnership.
Bigger than any one institution
This engagement is deliberate. The questions we study are bigger than any single institution, and the understanding we're after belongs to the field, not to us alone.
Our principal investigators are computational biologists, human geneticists, and clinician-scientists.
Start a conversationWhy non-profit
We chose this structure so we could work on what actually matters.
Non-profit was a deliberate choice, not a technicality.
A commercial lab answers to a return. That pressure decides which questions get asked: the ones with a near-term market, a defensible asset, a path to revenue. Enormous amounts of important biology fall outside those lines — rare conditions affecting too few people to justify a business case, negative results that save the field years, methods work that makes everyone's science better without belonging to anyone.
That work is exactly what we exist to do.
Being a non-profit means we can spend a year on a mechanism that may turn out to be a dead end, and publish it anyway, because the field is better for knowing. It means we can study a disease because it is poorly understood, not because it is profitable. It means our results can be given away rather than licensed.
We chose this structure because it is the only one that lets us follow the science where it actually leads.
Our mission
At the forefront of the craft, for the good of mankind
Our mission has two parts, and neither stands without the other.
First, to advance the craft itself — the methods, the standards of evidence, the discipline of reproducibility — so that biological research becomes more rigorous, more transparent, and more trustworthy over time.
Second, to advance the world's understanding of biology in service of human health — because every mechanism we clarify, every hypothesis we sharpen, is a step toward therapies and knowledge that can help people.
We do this work for the good of mankind. That is not a tagline — it is the standard we hold every study, case study, and editorial to.
“Understanding belongs to the field, not to any one institute.”REELD research principle